The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.

FMR LLC lifted its position in Vertex by 2.5% in the third quarter. FMR LLC now owns 2,287,774 shares of the company’s stock valued at $88,102,000 after acquiring an additional 54,985 shares ...

Truist Securities increased the price target for Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ: VRTX), a $121 ...

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

H&E Equipment Services, Inc. has a twelve month low of $40.92 and a twelve month high of $90.66. The stock has a market capitalization of $3.23 billion, a PE ratio of 22.38 and a beta of 1.93.